TUESDAY, March 29, 2022 (HealthDay News) — Despite months of intense lobbying by patient advocates, federal health officials on Monday posted a largely negative review of an experimental drug for the devastating illness known as amyotrophic lateral sclerosis (ALS). In an analysis of Amylyx Pharmaceuticals’ drug, known for now onlyContinue Reading

TUESDAY, March 29, 2022 (HealthDay News) — An experimental cream-based gene therapy may soon become the first U.S. government-approved means for treating a rare and devastating skin disease that produces “butterfly children.” Patients with recessive dystrophic epidermolysis bullosa (EB) are called butterfly children “because their skin is as fragile asContinue Reading

THURSDAY, March 24, 2022 (HealthDay News) — Recovering from hip or knee replacement surgery can be tough for anyone, but a new study from one hospital showed that Black patients were less likely than white patients to be satisfied with their care after the procedure. Researchers reviewed survey responses fromContinue Reading

TUESDAY, March 22, 2022 (HealthDay News) — Scars from facial surgery look worse to skin cancer patients themselves than to others, so it’s important for surgeons to prepare patients beforehand, researchers say. Doctors can help by outlining the healing process and explaining what their scars will look like in theContinue Reading